The price of this share is at 2,28$, Genetic Technologies Ltd is a company created in Australia dedicated to Biotechnology: Biological Products (No Diagnostic Substances) with its highest number of sales in Australia and South Pacific. Its Executives are Jerzy Muchnicki (Executive Director & Chief Medical Officer), Michael Tonroe (Chief Financial Officer & Secretary), Richard Allman (Chief Scientific Officer), Simon Morriss (Chief Executive Officer), Stan Sack (Chief Operating Officer) and its address is 60-66 HANOVER STREET P.O. BOX 115, FITZROY, MELBOURNE, 3065, Australia.
Today this action begins with yesterday's closing price, desconocido$.
With an intraday difference of 2,29$ moving between 2,23$ and 2,36$, it is a notable difference that allows quick purchases and sales.
The company has an annual revenue of desconocido.
The last value we have registered for the opening is desconocido.
To detect if it is a good time to enter or exit a stock, many traders use the lowest and highest values of the last 52 weeks. In this action, prices have moved between 0,00$ and 0,00$.
Earnings per share, or EPS, is a value also used to assess whether a company has obtained sufficient net profits for the number of shares it has for sale. In this case it is [BPA], but it must be taken into account that there may have been increases or decreases in capital that influence the value.